Global, regional, and national burden of depression, 1990-2021: a decomposition and age-period-cohort analysis with projection to 2040.

IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY
Journal of affective disorders Pub Date : 2025-12-15 Epub Date: 2025-08-07 DOI:10.1016/j.jad.2025.120018
Qianshu Xu, Zhengxue Qiao, Yuecui Kan, Bowen Wan, Xiaohui Qiu, Yanjie Yang
{"title":"Global, regional, and national burden of depression, 1990-2021: a decomposition and age-period-cohort analysis with projection to 2040.","authors":"Qianshu Xu, Zhengxue Qiao, Yuecui Kan, Bowen Wan, Xiaohui Qiu, Yanjie Yang","doi":"10.1016/j.jad.2025.120018","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Depression stands as one of the leading causes of disability worldwide. This study conducts a comprehensive analysis of the global burden of depression.</p><p><strong>Methods: </strong>Based on the Global Burden of Disease (GBD), we employed Joinpoint regression to analyze trends disease burden of depression globally from 1990 to 2021. The age-period-cohort (APC) model was employed to decompose the effects of age, period, and cohort, while the Das Gupta method quantified the contributions of aging, population growth, and epidemiological changes. A Bayesian age-period-cohort (BAPC) model was further utilized to project disease burden through 2040.</p><p><strong>Results: </strong>In 2021, the global age-standardized incidence, prevalence, and DALY rates of depression increased by 15.6 %, 11.3 %, and 13.4 %, compared to 1990, with average annual percentage changes (AAPCs) of 0.5 %, 0.4 %, and 0.4 %. APC analysis identified a peak age effect at 60-64 years, the highest period risk during 2017-2021, and a continuous rise in cohort risk after 1987. Cross-national inequality analysis revealed a higher burden in low-SDI countries (SII = -1981.7 per 100,000 in 2021), alongside widening health disparities among females. Decomposition analysis indicated that population growth accounted for 43.5 %-54.2 % of the global burden increase. BAPC projections estimated that by 2040, global age-standardized incidence, prevalence, and DALY rates would rise to 8478.2, 6927.8, and 1248.1 per 100,000.</p><p><strong>Conclusions: </strong>The global burden of depression continues to rise with significant inequalities. Prioritizing women, high-growth regions, and low-SDI countries is essential to address the escalating burden. This study provides critical evidence for optimizing resource allocation and developing interdisciplinary intervention plans.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"120018"},"PeriodicalIF":4.9000,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jad.2025.120018","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Depression stands as one of the leading causes of disability worldwide. This study conducts a comprehensive analysis of the global burden of depression.

Methods: Based on the Global Burden of Disease (GBD), we employed Joinpoint regression to analyze trends disease burden of depression globally from 1990 to 2021. The age-period-cohort (APC) model was employed to decompose the effects of age, period, and cohort, while the Das Gupta method quantified the contributions of aging, population growth, and epidemiological changes. A Bayesian age-period-cohort (BAPC) model was further utilized to project disease burden through 2040.

Results: In 2021, the global age-standardized incidence, prevalence, and DALY rates of depression increased by 15.6 %, 11.3 %, and 13.4 %, compared to 1990, with average annual percentage changes (AAPCs) of 0.5 %, 0.4 %, and 0.4 %. APC analysis identified a peak age effect at 60-64 years, the highest period risk during 2017-2021, and a continuous rise in cohort risk after 1987. Cross-national inequality analysis revealed a higher burden in low-SDI countries (SII = -1981.7 per 100,000 in 2021), alongside widening health disparities among females. Decomposition analysis indicated that population growth accounted for 43.5 %-54.2 % of the global burden increase. BAPC projections estimated that by 2040, global age-standardized incidence, prevalence, and DALY rates would rise to 8478.2, 6927.8, and 1248.1 per 100,000.

Conclusions: The global burden of depression continues to rise with significant inequalities. Prioritizing women, high-growth regions, and low-SDI countries is essential to address the escalating burden. This study provides critical evidence for optimizing resource allocation and developing interdisciplinary intervention plans.

1990-2021年全球、地区和国家抑郁症负担:预测到2040年的分解和年龄期队列分析
背景:抑郁症是全世界致残的主要原因之一。本研究对全球抑郁症负担进行了全面分析。方法:基于全球疾病负担(GBD),采用Joinpoint回归分析1990 - 2021年全球抑郁症疾病负担趋势。采用年龄-时期-队列(age-period-cohort, APC)模型分解年龄、时期和队列的影响,采用Das Gupta方法量化老龄化、人口增长和流行病学变化的影响。贝叶斯年龄-时期-队列(BAPC)模型进一步用于预测到2040年的疾病负担。结果:与1990年相比,2021年全球年龄标准化的抑郁症发病率、患病率和DALY率分别增加了15.6 %、11.3 %和13.4 %,年均百分比变化(AAPCs)分别为0.5 %、0.4 %和0.4 %。APC分析发现,年龄效应在60-64 岁时达到峰值,2017-2021年期间风险最高,1987年之后队列风险持续上升。跨国不平等分析显示,低sdi国家的负担更高(2021年SII = -1981.7 / 10万人),同时女性之间的健康差距也在扩大。分解分析表明,人口增长占全球负担增长的43.5 %-54.2 %。BAPC预测,到2040年,全球年龄标准化发病率、患病率和DALY率将上升至每10万人8478.2、6927.8和1248.1。结论:全球抑郁症负担持续上升,且存在显著的不平等。优先考虑妇女、高增长地区和低sdi国家对于解决日益加重的负担至关重要。本研究为优化资源配置和制定跨学科干预方案提供了重要依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of affective disorders
Journal of affective disorders 医学-精神病学
CiteScore
10.90
自引率
6.10%
发文量
1319
审稿时长
9.3 weeks
期刊介绍: The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信